Webinar on Infex's Phase II lead respiratory drug, RESP-X
On Jan 31st, Infex Therapeutics held a live webinar, to update on progress with…
Podcast: Will A ‘Netflix’ Model Solve Antibiotic Reimbursement Challenges And Spur R&D?
Listen to the podcast here Infex CEO Peter Jackson discusses the state of…
Antimicrobial discovery and drug development - RSC Podcast
How do we develop drugs like antibiotics? How long does it take for such a drug…
Industry group calls for action over £500m funding gap on AMR
Read the report here A life science industry report representing 36 key…
Podcast: Tackling The AMR Crisis
The issue of antimicrobial resistance (AMR) has been stalking global public…